TELROMA
DEAD

Serial Number

85835267

Owner

GLAXO GROUP LIMITED

Attorney

Christopher M. Hanes

Filing Date

Jan 29, 2013

Add to watchlist:

No watchlists yet
View on USPTO

TELROMA Trademark

Serial Number: 85835267

TELROMA is a trademark filed by GLAXO GROUP LIMITED on January 29, 2013. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

GLAXO GROUP LIMITED (5,077 trademarks)

980 Great West Road
Brentford, Middlesex TW89GS , GB

Entity Type: 03

Trademark Details

Filing Date

January 29, 2013

Registration Date

Not Registered

Published for Opposition

June 18, 2013

Goods & Services

(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(e)) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Sep 15, 2014 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 15, 2014 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 13, 2014 EXRA
SOU EXTENSION 1 GRANTED
Feb 11, 2014 EX1G
SOU EXTENSION 1 FILED
Feb 11, 2014 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 11, 2014 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 13, 2013 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 18, 2013 NPUB
PUBLISHED FOR OPPOSITION
Jun 18, 2013 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 29, 2013 NONP
ELECTRONIC RECORD REVIEW COMPLETE
May 13, 2013 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
May 10, 2013 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
May 6, 2013 CNSA
ASSIGNED TO EXAMINER
May 2, 2013 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 25, 2013 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 25, 2013 COAR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 4, 2013 NWOS
NEW APPLICATION ENTERED
Feb 1, 2013 NWAP